FDA Drug Application (090227) for AMOXICILLIN AND CLAVULANATE POTASSIUM by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number090227
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage1GM;EQ 62.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAMOXICILLIN AND CLAVULANATE POTASSIUM
Active IngredientAMOXICILLIN; CLAVULANATE POTASSIUM

Active IngredientCount
List of drugs with Active Ingredient AMOXICILLIN22
List of drugs with Active Ingredient CLAVULANATE POTASSIUM11


Back to FDA Applications sponsored by SANDOZ